JP2025503015A5 - - Google Patents
Info
- Publication number
- JP2025503015A5 JP2025503015A5 JP2024543009A JP2024543009A JP2025503015A5 JP 2025503015 A5 JP2025503015 A5 JP 2025503015A5 JP 2024543009 A JP2024543009 A JP 2024543009A JP 2024543009 A JP2024543009 A JP 2024543009A JP 2025503015 A5 JP2025503015 A5 JP 2025503015A5
- Authority
- JP
- Japan
- Prior art keywords
- beta
- cyp11β2
- subject
- hydroxylase inhibitor
- serum
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202263300967P | 2022-01-19 | 2022-01-19 | |
| US63/300,967 | 2022-01-19 | ||
| US202263400301P | 2022-08-23 | 2022-08-23 | |
| US63/400,301 | 2022-08-23 | ||
| PCT/IB2023/050444 WO2023139506A1 (en) | 2022-01-19 | 2023-01-19 | Methods of treating hypertension by periodic suppression of aldosterone synthase |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2025503015A JP2025503015A (ja) | 2025-01-30 |
| JP2025503015A5 true JP2025503015A5 (https=) | 2026-01-26 |
Family
ID=87347916
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024543009A Pending JP2025503015A (ja) | 2022-01-19 | 2023-01-19 | アルドステロン合成酵素を周期的に抑制することによる高血圧症の治療方法 |
Country Status (7)
| Country | Link |
|---|---|
| US (1) | US20250099475A1 (https=) |
| EP (1) | EP4466021A4 (https=) |
| JP (1) | JP2025503015A (https=) |
| KR (1) | KR20240140102A (https=) |
| CA (1) | CA3240577A1 (https=) |
| TW (1) | TW202339758A (https=) |
| WO (1) | WO2023139506A1 (https=) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2025527706A (ja) * | 2022-08-23 | 2025-08-22 | ミネラリス・セラピューティクス・インコーポレイテッド | 肥満対象における高血圧を治療する方法 |
| CA3265668A1 (en) * | 2022-08-23 | 2024-02-29 | Mineralys Therapeutics, Inc. | METHODS OF TREATING HYPERTENSION WITH A COMBINATION OF AN ALDOSTERONE SYNTHASE INHIBITOR AND A DIURETIC |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA2886117C (en) * | 2012-10-05 | 2022-05-31 | Merck Sharp & Dohme Corp. | Indoline compounds and their use as aldosterone synthase inhibitors |
| JP6067181B2 (ja) * | 2013-04-30 | 2017-01-25 | ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング | アルドステロンシンターゼ阻害薬 |
| MY176401A (en) * | 2014-04-24 | 2020-08-05 | Mitsubishi Tanabe Pharma Corp | Novel disubstituted 1,2,4-triazine compound |
| JP2023546970A (ja) * | 2020-10-26 | 2023-11-08 | ミネラリス・セラピューティクス・インコーポレイテッド | 高血圧のためのｃｙｐ１１ｂ２ベータヒドロキシラーゼ阻害剤 |
-
2023
- 2023-01-19 TW TW112102537A patent/TW202339758A/zh unknown
- 2023-01-19 EP EP23743048.3A patent/EP4466021A4/en active Pending
- 2023-01-19 WO PCT/IB2023/050444 patent/WO2023139506A1/en not_active Ceased
- 2023-01-19 JP JP2024543009A patent/JP2025503015A/ja active Pending
- 2023-01-19 CA CA3240577A patent/CA3240577A1/en active Pending
- 2023-01-19 US US18/730,540 patent/US20250099475A1/en active Pending
- 2023-01-19 KR KR1020247027543A patent/KR20240140102A/ko active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| RU2324482C2 (ru) | Комбинация органических соединений | |
| EP4212152B1 (en) | Sacubitril-valsartan dosage regimen for treating chronic systolic heart failure | |
| JP2023546970A5 (https=) | ||
| BRPI0306907B1 (pt) | composição farmacêutica, que compreende valsartan e inibidor de nep ou seus sais | |
| JP2025503015A5 (https=) | ||
| TW200831078A (en) | Angiotensin II receptor antagonist for the prevention or treatment of systemic diseases in cats | |
| EP2837380B1 (en) | Lercanidipine hydrochloride and losartan potassium compound preparation and preparation method thereof | |
| JP2002535367A5 (https=) | ||
| EP1307192B1 (en) | Candesartan for treating migraine | |
| EP4344701A1 (en) | Pharmaceutical composition comprising 1-(3-cyano-1-isopropyl-indol-5-yl)pyrazole-4-carboxylic acid | |
| EP4477223A1 (en) | Pharmaceutical composition comprising allopurinol, febuxostat or pharmaceutically acceptable salt thereof for prevention or treatment of chronic kidney disease in subject having high blood uric acid concentration | |
| JP6726138B2 (ja) | （３ｓ，３ｓ’）４，４’−ジスルファンジイルビス（３−アミノブタン １−スルホン酸）および第２の抗高血圧剤の組合せ | |
| US12336978B2 (en) | Pharmaceutical composition containing amlodipine, chlorthalidone, and amiloride and application thereof | |
| Mimran et al. | Maintenance of the antihypertensive efficacy of captopril despite consistent reduction in daily dosage. | |
| Waller | Drugs for heart failure and arrhythmias | |
| RU2024126016A (ru) | Лечение глиомы низкой степени злокачественности мирдаметинибом | |
| WO2006066235A1 (en) | Combination therapy for treating heart disease | |
| EP2482658B1 (en) | Methods and compositions for treatment of raynaud's phenomenon | |
| JPS61200917A (ja) | ベタキソロールとニフエジピンとを含有する医薬組成物 | |
| Kochar | Hypertension—An Overview | |
| Tang et al. | P-257: Levamlodipine therapy for hypertension after kidney transplantation | |
| KANTILAL | COMPARISON OF FOSINOPRIL, AND PROPRANOLOL, COMBINED WITH CHLORTHALIDONE IN THE TREATMENT OF MODERATELY TO SEVERELY HYPERTENSIVE BLACK AND | |
| WO2005074928A1 (ja) | 高血圧症治療薬 | |
| HK1148477A (en) | Combination of organic compounds | |
| HK1053609B (en) | Candesartan for treating migraine |